| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c26895e1df2ffdb5a7a07dc40911694c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-57 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-66 |
| filingDate |
1996-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95c07fcb846d56b5015cf4c72e6612d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc12dea43f6762c1fc56cf0f6e19549a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba99e8faae93bf3f7a77c6d7354764c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebecaaabe7b543b1f0fab076f77ead72 |
| publicationDate |
1997-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0812319-A1 |
| titleOfInvention |
2-arylbenzazole compounds |
| abstract |
There are disclosed herein 2-phenylbenzazole compounds having a 3'-substituent and a 4'-NR2R6 substituent in the phenyl group where R5 and R6 are each hydrogen or alkyl, or where the $'-NR5R6 substituent is N-acyl (or N-benzoyl). There are also disclosed 2-phenylbenzazole compounds in the form of 4'-N sulphamate salts. Such compounds exhibit significant selective cytotoxic activity in respect of tumor cells and provide potentially useful chemotherapeutic agents for selective treatment of a range of cancers. |
| priorityDate |
1995-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |